Bazell, R.: Panel sanctions amphetamines for hyperkinetic children. Science171: 1223, 1971.
2.
McAndrew, J.B. , Case, Q., and Treffert, D.A.: Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. J. Autism Child. Schiz.2: 75, 1972.
3.
Polizos, P., Engelhardt, D., and Hoffman, S.P.: CNS consequences of psychotropic drug withdrawal in schizophrenic children . Psychopharm. Bull.9: 34, 1973.
4.
Wender, P.H.: Minimal Brain Dysfunction in Children. New York, John Wiley & Sons, 1971.
5.
Conners, C.K.: Drugs in the management of children with learning disabilities. In Tarnopol, L. Ed.: Learning Disorders in Children: Diagnosis, Medication, Education. Boston, Little, Brown & Co., 1971, p. 253.
6.
Winsberg, B.G. , Press, M., Bialer, I., and Kupietz, S.: Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children. Pediatrics53: 236, 1974.
7.
Espelin, D.E. , and Done, A.K.: Amphetamine poisoning: effectiveness of chlorpromazine. N. Engl. J. Med.278: 1361, 1968 .
8.
Safer, D., Allen, R., and Barr, E.: Depression of growth in hyperactive children on stimulant drugs. N. Engl. J. Med.287: 217, 1972.
9.
Livingston, S., Berman, W., and Pauli, L.L.: Stimulant drugs for problem children. N. Engl. J. Med.239: 1375, 1973 (letter).
10.
Laufer, M.W. : Long-term management and some follow-up findings on the use of drugs with minimal cerebral syndromes. J. Learn. Dis.4: 55, 1971.
11.
Winsberg, B.G. , Bialer, I., Kupietz, S., and Tobias, J.: Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children. Am. J. Psychiatr.128: 1425, 1972.
12.
Rappaport, J.L., Quinn, P.O., Bradbard, G., Riddle, K.D., and Brooks, E.: Imipramine and methylphenidate treatment of hyperactive boys. Arch. Gen. Psychiatr. 30: 789, 1974.
13.
Waizer, J., Hoffman, S.P., Polizos, P., and Engelhardt, D.M. : Outpatient treatment of hyperactive schoolchildren with imipramine. Am. J. Psychiatr.131: 587, 1974 .
14.
Brown, D., Winsberg, B.G., Bialer, I., and Press, M.: Imipramine therapy and seizures: three children treated for hyperactive behavior disorders. Am. J. Psychiatr.130: 210, 1973 .
15.
Winsberg, B.G. , Goldstein, S., Yepes, L.E., and Perel, J.M.: Imipramine and electrocardiographic abnormalities in hyperactive children. Am. J. Psychiatr.132: 542, 1975.
16.
—, Perel, J., Hurwic, M., and Klutch, A.: Factors in imipramine metabolism in children: protein binding considerations. In Forrest, I. S., Carr, C. J., and Usdin, E., Eds.: Phenothiazines and Structurally Related Compounds (Advances in Biochemical Psycopharmacology: Vol. 9). New York, Raven Press, 1974, p. 425.
17.
Kraft, I. A., Ardali, C., Duffy, J., et al.: Use of amitriptyline in childhood behavior disturbances. Int. J. Neuropsychiatr.2: 611, 1966.
18.
Krakowski, A.J.: Amitriptyline in treatment of hyperkinetic children: a double blind study. Psychosomatics6: 355, 1965.
19.
Shader, R. I., and DiMascio, A., Eds.: Psychotropic Drug Side Effects: Clinical and Theoretical Perspectives. Baltimore, Williams & Wilkins Co., 1970.
20.
Faretra, G. , Dooker, L., and Dowling, J.: Comparison of haloperidol and fluphenazine in disturbed children. Am. J. Psychiatr.126: 1670, 1970 .
21.
Crane, G.E. : Tardive dyskinesia in patients treated with major neuroleptics: review of the literature. Am. J. Psychiatr.124: 40, 1968.